Xilio Therapeutics (XLO) Q1 2025 Earnings

Mar 11Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.62
-0.45
-0.28
-0.11

Details

Expected EPS
-0.2167
Actual EPS
-0.2
Surprise EPS
0.02
Surprise Percent
+7.71%

Description

⁨Xilio Therapeutics⁩ (⁦XLO⁩) has reported earnings of ⁦-0.2⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts